Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 341723, 11 pages
http://dx.doi.org/10.1155/2015/341723
Review Article

Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes

1Department of Oncology, Haematology and Respiratory Diseases, University Hospital of Modena, 41124 Modena, Italy
2Department of Obstetrics Gynecology and Pediatrics, Obstetrics and Gynecology Unit, University Hospital of Modena, 41124 Modena, Italy
3Department of Medical Oncology, Kimmel Cancer Center, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA

Received 2 January 2015; Revised 27 April 2015; Accepted 29 April 2015

Academic Editor: Stefan Rimbach

Copyright © 2015 Angela Toss et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [35 citations]

The following is the list of published articles that have cited the current article.

  • Elisabete Weiderpass, and Jerzy E. Tyczynski, “Epidemiology of Patients with Ovarian Cancer with and Without a BRCA1/2 Mutation,” Molecular Diagnosis & Therapy, 2015. View at Publisher · View at Google Scholar
  • Brandon S. Sheffield, Veronica Hirsch-Reinshagen, and Kasmintan A. Schrader, “How to Screen for Hereditary Cancers in General Pathology Practice,” Archives of Pathology & Laboratory Medicine, vol. 140, no. 9, pp. 899–909, 2016. View at Publisher · View at Google Scholar
  • Paula C. Brady, Paula C. Brady, and Daniel J. Kaser, “Adnexal Masses and Ovarian Cyst Rupture,” Handbook of Consult and Inpatient Gynecology, pp. 79–111, 2016. View at Publisher · View at Google Scholar
  • Sebastian Häusler, Achim Wöckel, and Monika Rehn, “Diagnostik und Management von Adnexraumforderungen,” Der Gynäkologe, 2016. View at Publisher · View at Google Scholar
  • Cynthia A. Thomson, Tracy E. Crane, Austin Miller, David O. Garcia, Karen Basen-Engquist, and David S. Alberts, “A randomized trial of diet and physical activity in women treated for stage II–IV ovarian cancer: Rationale and design of the Lifestyle Intervention for Ovarian Cancer Enhanced Survival (LIVES): An NRG Oncology/Gynecologic Oncology Group (GOG-225) Study,” Contemporary Clinical Trials, 2016. View at Publisher · View at Google Scholar
  • Gaurav Goyal, Tiffany Fan, and Peter Todd Silberstein, “Hereditary cancer syndromes: utilizing DNA repair deficiency as therapeutic target,” Familial Cancer, 2016. View at Publisher · View at Google Scholar
  • Natalia Jančárková, “Female Reproductive System and Cancer,” Cancer Genetics and Psychotherapy, pp. 451–498, 2017. View at Publisher · View at Google Scholar
  • Masayuki Sekine, and Takayuki Enomoto, “Hereditary Ovarian Cancer,” Frontiers in Ovarian Cancer Science, pp. 15–35, 2017. View at Publisher · View at Google Scholar
  • Y Gunawan, and H Winarto, “Body weight, hemoglobin, and absolute neutrophil count in patients with advanced-stage epithelial ovarian cancer who received chemotherapy: A single-center study,” Journal of Physics: Conference Series, vol. 884, pp. 012029, 2017. View at Publisher · View at Google Scholar
  • Nuria Romero-Laorden, and Elena Castro, “Inherited mutations in DNA repair genes and cancer risk,” Current Problems in Cancer, vol. 41, no. 4, pp. 251–264, 2017. View at Publisher · View at Google Scholar
  • Raffaele Palmirotta, Erica Silvestris, Stella D?Oronzo, Angela Cardascia, and Franco Silvestris, “Ovarian cancer: novel molecular aspects for clinical assessment,” Critical Reviews in Oncology/Hematology, 2017. View at Publisher · View at Google Scholar
  • Xiao-Tian Yao, Li-Wei Zhang, Hui-Ying Pan, Tian-Qin Wang, Xiao-Xin Zhou, and Yu Wang, “Prognostic significance of preoperative peripheral blood neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with ovarian cancer,” Journal of Shanghai Jiaotong University (Medical Science), vol. 37, no. 5, pp. 627–631, 2017. View at Publisher · View at Google Scholar
  • Sarah M. Temkin, Jennifer Bergstrom, Goli Samimi, and Lori Minasian, “Ovarian Cancer Prevention in High-risk Women,” Clinical Obstetrics and Gynecology, vol. 60, no. 4, pp. 738–757, 2017. View at Publisher · View at Google Scholar
  • Divya Vimal, Saurabh Kumar, Ashutosh Pandey, Divya Sharma, Sanjay Saini, Snigdha Gupta, Kristipati Ravi Ram, and Debapratim Kar Chowdhuri, “Mlh1 is required for female fertility in Drosophila melanogaster : An outcome of effects on meiotic crossing over, ovarian follicles and egg activation,” European Journal of Cell Biology, 2017. View at Publisher · View at Google Scholar
  • Michael G. Muto, Christopher P. Crum, Ann K. Folkins, Elke A. Jarboe, and Jonathan L. Hechtpp. 844–864, 2017. View at Publisher · View at Google Scholar
  • Giovanni Grandi, Angela Toss, Angelo Cagnacci, Luigi Marcheselli, Silvia Pavesi, Fabio Facchinetti, Stefano Cascinu, and Laura Cortesi, “Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History,” Clinical Breast Cancer, 2017. View at Publisher · View at Google Scholar
  • Ileana W. Carnevali, Laura Cimetti, Nora Sahnane, Laura Libera, Alessandra Cavallero, Giorgio Formenti, Cristina Riva, and Maria Grazia Tibiletti, “Two Cases of Carcinosarcomas of the Ovary Involved in Hereditary Cancer Syndromes,” International Journal of Gynecological Pathology, vol. 36, no. 1, pp. 64–70, 2017. View at Publisher · View at Google Scholar
  • Myong Cheol Lim, and Leslie M. Randall, “Role and clinical application of next-generation sequencing (NGS) for ovarian cancer,” Journal of Gynecologic Oncology, vol. 28, 2017. View at Publisher · View at Google Scholar
  • Akira Hirasawa, Takuya Naruto, Tomoko Akahane, Wataru Yamagami, Nobuyuki Susumu, Daisuke Aoki, Issei Imoto, Hiroyuki Nomura, Kiyoshi Masuda, and Hitoshi Tsuda, “Prevalence of pathogenic germline variants detected by multigene sequencing in unselected Japanese patients with ovarian cancer,” Oncotarget, vol. 8, no. 68, pp. 112258–112267, 2017. View at Publisher · View at Google Scholar
  • Hsiao-Mei Lu, Shuwei Li, Mary Helen Black, Shela Lee, Robert Hoiness, Sitao Wu, Wenbo Mu, Robert Huether, Jefferey Chen, Srijani Sridhar, Yuan Tian, Rachel McFarland, Jill Dolinsky, Brigette Tippin Davis, Sharon Mexal, Charles Dunlop, and Aaron Elliott, “Association of Breast and Ovarian Cancers With Predisposition Genes Identified by Large-Scale Sequencing,” JAMA Oncology, 2018. View at Publisher · View at Google Scholar
  • Sudha Savant, Shruthi Sriramkumar, and Heather O’Hagan, “The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer,” Cancers, vol. 10, no. 8, pp. 251, 2018. View at Publisher · View at Google Scholar
  • Tomás Reinert, Angélica Nogueira-Rodrigues, Fabiola Procacci Kestelman, Patricia Ashton-Prolla, Márcia Silveira Graudenz, and José Bines, “The challenge of evaluating adnexal masses in breast cancer patients,” Clinical Breast Cancer, 2018. View at Publisher · View at Google Scholar
  • Richard I. Shader, “Reflections on Oncotherapies,” Clinical Therapeutics, 2018. View at Publisher · View at Google Scholar
  • Xiugui Sheng, Yan Zhong, Chunhua Lu, Jingwei Peng, Hao Yu, and Jing Guo, “Clinical study of hereditary ovarian cancer syndrome in Shandong province, East China,” International Journal of Gynecology & Obstetrics, 2018. View at Publisher · View at Google Scholar
  • Magdalena Koczkowska, Natalia Krawczynska, Maciej Stukan, Alina Kuzniacka, Izabela Brozek, Marcin Sniadecki, Jaroslaw Debniak, Dariusz Wydra, Wojciech Biernat, Piotr Kozlowski, Janusz Limon, Bartosz Wasag, and Magdalena Ratajska, “Spectrum and Prevalence of Pathogenic Variants in Ovarian Cancer Susceptibility Genes in a Group of 333 Patients,” Cancers, vol. 10, no. 11, pp. 442, 2018. View at Publisher · View at Google Scholar
  • Brian T. Burgess, and Jill M. Kolesar, “Defective DNA repair in hereditary ovarian cancers: Implications for therapy,” American Journal of Health-System Pharmacy, vol. 75, no. 21, pp. 1697–1707, 2018. View at Publisher · View at Google Scholar
  • Aline Brito de Lima, Luciana Maria Silva, Nikole Gontijo Gonçales, Maria Raquel Santos Carvalho, Agnaldo Lopes da Silva Filho, and Letícia da Conceição Braga, “Three-Dimensional Cellular Arrangement in Epithelial Ovarian Cancer Cell Lines TOV-21G and SKOV-3 is Associated with Apoptosis-Related miRNA Expression Modulation,” Cancer Microenvironment, 2018. View at Publisher · View at Google Scholar
  • Aus Tariq Ali, “Towards prevention of ovarian cancer,” Current Cancer Drug Targets, vol. 18, no. 6, pp. 522–537, 2018. View at Publisher · View at Google Scholar
  • Laura Cortesi, Angela Toss, and Iole Cucinotto, “PARP inhibitors for the treatment of ovarian cancer,” Current Cancer Drug Targets, vol. 18, no. 9, pp. 877–893, 2018. View at Publisher · View at Google Scholar
  • Andrew F. Wagner, Lee P. Shulman, and Jeffrey S. Dungan, “Cancer Genetics: Risks and Mechanisms of Cancer in Women with Hereditary Predisposition to Epithelial Ovarian Cancer,” Textbook of Oncofertility Research and Practice, pp. 29–43, 2019. View at Publisher · View at Google Scholar
  • Shuyun Xu, Zhenzhen Liu, Meihua Lv, Yuli Chen, and Ya Liu, “Intestinal dysbiosis promotes epithelial-mesenchymal transition by activating tumor-associated macrophages in ovarian cancer,” Pathogens and Disease, vol. 77, no. 2, 2019. View at Publisher · View at Google Scholar
  • Beata Smolarz, Magdalena M. Michalska, Dariusz Samulak, Hanna Romanowicz, and Luiza Wójcik, “Polymorphism of DNA Repair Genes via Homologous Recombination (HR) in Ovarian Cancer,” Pathology & Oncology Research, 2019. View at Publisher · View at Google Scholar
  • Ratika Samtani, and Deepti Saksena, “BRCA gene mutations: A population based review,” Gene Reports, pp. 100380, 2019. View at Publisher · View at Google Scholar
  • Ana Krivokuca, Ivana Boljevic, Stevo Jovandic, Zvonko Magic, Aljosa Mandic, Zorica Tomasevic, and Mirjana Brankovic-Magic, “Germline mutations in cancer susceptibility genes in high grade serous ovarian cancer in Serbia,” Journal of Human Genetics, 2019. View at Publisher · View at Google Scholar
  • Hisanori Fukunaga, Akinari Yokoya, Yasuyuki Taki, Karl T. Butterworth, and Kevin M. Prise, “Precision Radiotherapy and Radiation Risk Assessment: How Do We Overcome Radiogenomic Diversity?,” The Tohoku Journal of Experimental Medicine, vol. 247, no. 4, pp. 223–235, 2019. View at Publisher · View at Google Scholar